FranΓ§aisπ See the interactive version (live chart) β
For Veeva Systems, we replayed every analyst price target of the past 12 months and measured the real outcome: 51% were profitable, average return +19% (281 calls). At 3 months: +2% average return (40% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 31 | 71% | +32% |
| Needham | 25 | 40% | +9% |
| Piper Sandler | 25 | 52% | +16% |
| Keybanc | 21 | 57% | +20% |
| Stifel | 18 | 67% | +36% |
Is Veeva Systems overvalued, and is it a good time to buy Veeva Systems right now? If you're wondering, here's a recap to make up your own mind: Veeva Systems's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Veeva Systems | Sector median (Health Care) |
|---|---|---|
| P/E | 46.3 | 29.4 |
| Forward P/E | 27.6 | 17.1 |
| Net margin | 28% | 12% |
π Veeva Systems trades above its sector median (46.3 vs 29.4) β the market expects higher growth; watch out for disappointment.
π P/E, PEG, marginβ¦: see the glossary
The analyst consensus on Veeva Systems (VEEV) is "Buy" (49 bullish, 2 bearish calls over 12 months). This is not advice: historically, 51% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $266 (-6% vs $282), ranging from $165 to $340 (20 analysts).
Over 1 year, 51% of analyst targets on Veeva Systems were profitable, for an average return of +19% (across 281 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $266 within 12 months, i.e. -6% vs the current price. The most bullish targets $340, the most cautious $165.
Note: analyst targets are 12-month (median $266, -6%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (51%), and the stock's past trajectory.
Its P/E is 46.3, forward P/E 27.6. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Veeva Systems β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.